I agree that this site is using cookies. You can find further informations here.
X
Cilloni, Daniela
336  results:
Search for persons X
?
1

Comprehensive Molecular Profiling of NPM1-Mutated Acute Mye..:

Petiti, Jessica ; Pignochino, Ymera ; Schiavon, Aurora...
International Journal of Molecular Sciences.  25 (2024)  7 - p. 3631 , 2024
Link: https://doi.org/10.3390/..
 
?
2

A Radiation-Free Approach Based on the Whole-Body MRI Has S..:

Frolli, Antonio ; Varvello, Sivlia ; Balbo Mussetto, Annalisa...
Journal of Clinical Medicine.  13 (2024)  13 - p. 3637 , 2024
Link: https://doi.org/10.3390/..
 
?
3

Olutasidenib (FT-2102) induces durable complete remissions ..:

de Botton, Stéphane ; Fenaux, Pierre ; Yee, Karen...
Blood Advances.  7 (2023)  13 - p. 3117-3127 , 2023
Link: https://doi.org/10.1182/..
 
?
4

Italian Physicians' Perceptions about the Role of Asciminib..:

Breccia, Massimo ; Piciocchi, Alfonso ; Abruzzese, Elisabetta...
Journal of Clinical Medicine.  12 (2023)  16 - p. 5267 , 2023
Link: https://doi.org/10.3390/..
 
?
5

Determinants of Covid19 disease and of survival after Covid..:

Palandri, Francesca ; Elli, Elena M. ; Auteri, Giuseppe...
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
6

Incidence of blast phase in myelofibrosis patients accordin..:

Palandri, Francesca ; Palumbo, Giuseppe A. ; Benevolo, Giulia...
Cancer.  130 (2023)  8 - p. 1270-1280 , 2023
Link: https://doi.org/10.1002/..
 
?
7

PB2672: EXPLORING UNMET NEEDS OF PATIENTS WITH MYELODYSPLAS..:

Crisà, Elena ; Nosari, Annamaria ; Cilloni, Daniela...
HemaSphere.  7 (2023)  S3 - p. e9792183 , 2023
Link: https://doi.org/10.1097/..
 
?
8

Real‐world efficacy and safety of luspatercept and predicti..:

Lanino, Luca ; Restuccia, Francesco ; Perego, Alessandra...
American Journal of Hematology.  98 (2023)  8 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
9

A Leukemic Target with a Thousand Faces: The Mitochondria:

Maffeo, Beatrice ; Panuzzo, Cristina ; Moraca, Amedeo.
International Journal of Molecular Sciences.  24 (2023)  17 - p. 13069 , 2023
Link: https://doi.org/10.3390/..
 
?
10

P1024: MYLOX-1: A PHASE II STUDY EVALUATING THE SAFETY, TOL..:

Harrison, Claire ; Mascarenhas, John ; Cilloni, Daniela...
HemaSphere.  7 (2023)  S3 - p. e87048d4 , 2023
Link: https://doi.org/10.1097/..
 
?
11

Ruxolitinib in cytopenic myelofibrosis: Response, toxicity,..:

Palandri, Francesca ; Breccia, Massimo ; Mazzoni, Camilla...
Cancer.  129 (2023)  11 - p. 1704-1713 , 2023
Link: https://doi.org/10.1002/..
 
?
12

mTORC2 Is Activated under Hypoxia and Could Support Chronic..:

Panuzzo, Cristina ; Pironi, Lucrezia ; Maglione, Alessandro...
International Journal of Molecular Sciences.  24 (2023)  2 - p. 1234 , 2023
Link: https://doi.org/10.3390/..
 
?
13

AVALON: The Italian cohort study on real‐life efficacy of h..:

Todisco, Elisabetta ; Papayannidis, Cristina ; Fracchiolla, Nicola...
Cancer.  129 (2023)  7 - p. 992-1004 , 2023
Link: https://doi.org/10.1002/..
 
?
14

PB2177: MULTICENTRE RETROSPECTIVE OBSERVATIONAL STUDY ON PA..:

Bonuomo, Valentina ; Armenio, Marco ; Cilloni, Daniela...
HemaSphere.  7 (2023)  S3 - p. e70865df , 2023
Link: https://doi.org/10.1097/..
 
?
15

A Prognostic Model to Predict Ruxolitinib Discontinuation a..:

Palandri, Francesca ; Palumbo, Giuseppe A. ; Bonifacio, Massimiliano...
Cancers.  15 (2023)  20 - p. 5027 , 2023
Link: https://doi.org/10.3390/..
 
1-15